


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app58.us.archive.org';v.server_ms=641;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->
    <!-- ForeSee Code -->
    <script type="text/javascript">

        // Foresee survey call
        // Answers Cloud Services Embed Script v1.02
        // DO NOT MODIFY BELOW THIS LINE *****************************************
        ; (function (g) {
            var d = document, i, am = d.createElement('script'), h = d.head || d.getElementsByTagName("head")[0],
                aex = {
                    "src": "//web.archive.org/web/20170701134201/https://gateway.answerscloud.com/qualitymeasures-ahrq-gov/production/gateway.min.js",
                    "type": "text/javascript",
                    "async": "true",
                    "data-vendor": "acs",
                    "data-role": "gateway"
                };
            for (var attr in aex) { am.setAttribute(attr, aex[attr]); }
            h.appendChild(am);
            g['acsReady'] = function () { var aT = '__acsReady__', args = Array.prototype.slice.call(arguments, 0), k = setInterval(function () { if (typeof g[aT] === 'function') { clearInterval(k); for (i = 0; i < args.length; i++) { g[aT].call(g, function (fn) { return function () { setTimeout(fn, 1) }; }(args[i])); } } }, 50); };
        })(window);
        // DO NOT MODIFY ABOVE THIS LINE *****************************************
    </script>
    <!-- End ForeSee Code -->


        <title>Prostate cancer: percentage of patients, regardless of age, with a diagnosis of prostate cancer at high or very high risk of recurrence, receiving external beam radiotherapy to the prostate who were prescribed adjuvant hormonal therapy (GnRH agonist or antagonist). | National Quality Measures Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20170701134201im_/https://qualitymeasures.ahrq.gov/UI/images/favicon-NQMC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20170701134201im_/https://qualitymeasures.ahrq.gov/UI/images/apple-touch-icon-NQMC.png">
    <link rel="icon" type="image/png" href="/web/20170701134201im_/https://qualitymeasures.ahrq.gov/UI/images/favicon-NQMC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20170701134201im_/https://qualitymeasures.ahrq.gov/UI/images/favicon-NQMC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20170701134201/https://qualitymeasures.ahrq.gov/UI/images/manifest-NQMC.json">
    <link rel="mask-icon" href="/web/20170701134201im_/https://qualitymeasures.ahrq.gov/UI/images/safari-pinned-tab-NQMC.svg" color="#222c66">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20170701134201cs_/https://qualitymeasures.ahrq.gov/cassette.axd/stylesheet/3a1406960f01c082e8cd734e7c19b87ae6d17b1b/NQMCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type ="text javascript" id="_fed_an_ua_tag" src="https://dap.digitalgov.gov/Universal­Federated­Analytics­Min.js?agency=AHRQ&amp;pua=UA-61009437-1"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20170701134201if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20170701134201/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20170701134201if_/https://www.googletagmanager.com/ns.html?id=GTM-KXQCDQ" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20170701134201/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KXQCDQ');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20170701134201/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20170701134201/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/" class="header-logo NQMC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20170701134201im_/https://qualitymeasures.ahrq.gov/UI/images/logo_NQMC_header.png">
				        <source srcset="/web/20170701134201im_/https://qualitymeasures.ahrq.gov/UI/images/logo_NQMC_header_m.png">
				        <img src="/web/20170701134201im_/https://qualitymeasures.ahrq.gov/UI/images/logo_NQMC_header.png" alt="National Quality Measures Clearinghouse">
				    </picture>
				</a>
<form action="/web/20170701134201/https://qualitymeasures.ahrq.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20170701134201/https://qualitymeasures.ahrq.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NQMC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20170701134201/https://qualitymeasures.ahrq.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/">Home</a></li>
		        <li class=""><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/new-this-week/index">New This Week</a></li>
		        <li>
                    <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/browse" class="parent-link">Measure Summaries</a>		            <ul class="level-2 dropdown">
		                    <li class=""><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/browse/domain">By Measure Domain</a></li>
                            <li class=""><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/browse/setting">By Measurement Setting</a></li>
		                <li class=""><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_DocType=302&amp;fLockTerm=Measure Summaries">All Summaries</a></li>
		            </ul>
		        </li>
		        <li class=""><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/matrix">Matrix Tool</a></li>
		        <li class="">
                    <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/submit">Submit Measures</a>		        </li>
                <li class=""><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
	</div><!-- /.header -->

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Measure Summary</li>
            <li>NQMC:010102</li>
            <li>Nov 2014
            </li>            
                <li>
                    <span class="nqf">NQF-Endorsed Measure</span>
                </li>    
                    </ul>
        <div>
                <h1>Prostate cancer: percentage of patients, regardless of age, with a diagnosis of prostate cancer at high or very high risk of recurrence, receiving external beam radiotherapy to the prostate who were prescribed adjuvant hormonal therapy (GnRH agonist or antagonist).</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_Developer_String=American%20Urological%20Association&amp;fLockTerm=American%2BUrological%2BAssociation">American Urological Association</a></li>
                        <li>   
                                <a id="2030" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
        <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_Developer_String=Physician%20Consortium%20for%20Performance%20Improvement%C2%AE&amp;fLockTerm=Physician%2BConsortium%2Bfor%2BPerformance%2BImprovement%25c2%25ae">Physician Consortium for Performance Improvement&#174;</a></li>
                        <li>   
                                <a id="1332" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>American Urological Association (AUA), American Medical Association-convened Physician Consortium for Performance Improvement® (PCPI®). Prostate cancer physician performance measurement set. Linthicum (MD): American Urological Association (AUA); 2014 Nov. 19 p. </td></tr></table><fieldvalue value="<table><tr><td>American Urological Association (AUA), American Medical Association-convened Physician Consortium for Performance Improvement® (PCPI®). Prostate cancer physician performance measurement set. Linthicum (MD): American Urological Association (AUA); 2014 Nov. 19 p. </td></tr></table>"/>            </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the measure.</p>
<p>This measure updates a previous version: American Urological Association, American Medical Association (AMA)-convened Physician Consortium for Performance Improvement&reg;. Prostate cancer physician performance measurement set. Chicago (IL): American Medical Association (AMA); 2012 Sep. 28 p. </p>
<p>The measure developer reaffirmed the currency of this measure in February 2017. </p></div><fieldvalue value="<div class=&quot;content_para&quot;><p>This is the current release of the measure.</p>
<p>This measure updates a previous version: American Urological Association, American Medical Association (AMA)-convened Physician Consortium for Performance Improvement&amp;reg;. Prostate cancer physician performance measurement set. Chicago (IL): American Medical Association (AMA); 2012 Sep. 28 p. </p>
<p>The measure developer reaffirmed the currency of this measure in February 2017. </p></div>"/></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
            <h4>Measure Hierarchy</h4>
<a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_Collection_Hierarchy=objid49066&amp;fLockTerm=Prostate%2BCancer%2BPhysician%2BPerformance%2BMeasurement%2BSet">Prostate Cancer Physician Performance Measurement Set</a>                    <h4>Age Group</h4>
            <ul>
                        <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Unspecified&amp;fLockTerm=Unspecified">Unspecified</a></li>                                              
            </ul>
                    <h4>UMLS Concepts <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_ICD9CM_CUI=C0376358&amp;fLockTerm=Malignant+neoplasm+of+prostate">Malignant neoplasm of prostate</a>
 (185), <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_ICD9CM_CUI=C0085203&amp;fLockTerm=Stereotactic+radiosurgery%2c+not+otherwise+specified">Stereotactic radiosurgery, not otherwise specified</a>
 (92.30)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0282559&amp;fLockTerm=Antineoplastic+Agents%2c+Hormonal">Antineoplastic Agents, Hormonal</a>
, <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0085533&amp;fLockTerm=Chemotherapy%2c+Adjuvant">Chemotherapy, Adjuvant</a>
, <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0023610&amp;fLockTerm=Gonadotropin-Releasing+Hormone">Gonadotropin-Releasing Hormone</a>
, <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0027643&amp;fLockTerm=Neoplasm+Recurrence%2c+Local">Neoplasm Recurrence, Local</a>
, <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0033578&amp;fLockTerm=Prostatic+Neoplasms">Prostatic Neoplasms</a>
, <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0085203&amp;fLockTerm=Radiosurgery">Radiosurgery</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_MTH_CUI=C0023610&amp;fLockTerm=Gonadorelin">Gonadorelin</a>
, <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_MTH_CUI=C1268855&amp;fLockTerm=Gonadotropin+releasing+hormone+antagonist">Gonadotropin releasing hormone antagonist</a>
, <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_MTH_CUI=C1268900&amp;fLockTerm=Gonadotropin-Releasing+Hormone+Analog">Gonadotropin-Releasing Hormone Analog</a>
, <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_MTH_CUI=C0279025&amp;fLockTerm=Hormone+Therapy">Hormone Therapy</a>
, <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_MTH_CUI=C0376358&amp;fLockTerm=Malignant+neoplasm+of+prostate">Malignant neoplasm of prostate</a>
, <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_MTH_CUI=C0033578&amp;fLockTerm=Prostatic+Neoplasms">Prostatic Neoplasms</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_PDQ_CUI=C0023610&amp;fLockTerm=gonadorelin">gonadorelin</a>
, <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_PDQ_CUI=C0279025&amp;fLockTerm=hormone+therapy">hormone therapy</a>
, <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_PDQ_CUI=C0085203&amp;fLockTerm=stereotactic+radiosurgery">stereotactic radiosurgery</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0023610&amp;fLockTerm=Gonadorelin">Gonadorelin</a>
 (325995009), <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0023610&amp;fLockTerm=Gonadorelin">Gonadorelin</a>
 (397197007), <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0023610&amp;fLockTerm=Gonadorelin">Gonadorelin</a>
 (49869009), <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0023610&amp;fLockTerm=Gonadorelin">Gonadorelin</a>
 (75969007), <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C1268855&amp;fLockTerm=Gonadotropin+releasing+hormone+antagonist">Gonadotropin releasing hormone antagonist</a>
 (116101001), <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C1268855&amp;fLockTerm=Gonadotropin+releasing+hormone+antagonist">Gonadotropin releasing hormone antagonist</a>
 (395962005), <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C1268900&amp;fLockTerm=Gonadotropin-releasing+hormone+analog">Gonadotropin-releasing hormone analog</a>
 (108772001), <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0279025&amp;fLockTerm=Hormone+therapy">Hormone therapy</a>
 (169413002), <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0279025&amp;fLockTerm=Hormone+therapy">Hormone therapy</a>
 (309542002), <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0376358&amp;fLockTerm=Malignant+tumor+of+prostate">Malignant tumor of prostate</a>
 (399068003), <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0033578&amp;fLockTerm=Neoplasm+of+prostate">Neoplasm of prostate</a>
 (126906006), <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0085203&amp;fLockTerm=Stereotactic+radiotherapy">Stereotactic radiotherapy</a>
 (115959002), <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0085203&amp;fLockTerm=Stereotactic+radiotherapy">Stereotactic radiotherapy</a>
 (395096001)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
    <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#563" class="section-mark">Measure Domain</a></li>
                                    <li><a href="#566" class="section-mark">Brief Abstract</a></li>
                                    <li><a href="#573" class="section-mark">Evidence Supporting the Measure</a></li>
                                    <li><a href="#580" class="section-mark">State of Use of the Measure</a></li>
                                    <li><a href="#583" class="section-mark">Application of the Measure in its Current Use</a></li>
                                    <li><a href="#660" class="section-mark">National Strategy for Quality Improvement in Health Care</a></li>
                                    <li><a href="#590" class="section-mark">Institute of Medicine (IOM) National Health Care Quality Report Categories</a></li>
                                    <li><a href="#593" class="section-mark">Data Collection for the Measure</a></li>
                                    <li><a href="#605" class="section-mark">Computation of the Measure</a></li>
                                    <li><a href="#615" class="section-mark">Identifying Information</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/downloadcontent/nqmc-10102?contentType=pdf" class="pdf">.PDF 116.8 kb</a></li>
                            <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/downloadcontent/nqmc-10102?contentType=word" class="word">Word Document 51.1 kb</a></li>
                            <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/downloadcontent/nqmc-10102?contentType=xml" class="xml">.XML 34.0 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20170701134201/https://www.facebook.com/sharer/sharer.php?u=https://qualitymeasures.ahrq.gov/summaries/summary/49129/prostate-cancer-percentage-of-patients-regardless-of-age-with-a-diagnosis-of-prostate-cancer-at-high-or-very-high-risk-of-recurrence-receiving-external-beam-radiotherapy-to-the-prostate-who-were-prescribed-adjuvant-hormonal-therapy-gnrh-agonist-or-antagonist" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20170701134201/https://twitter.com/share?text=&amp;url=https://qualitymeasures.ahrq.gov/summaries/summary/49129/prostate-cancer-percentage-of-patients-regardless-of-age-with-a-diagnosis-of-prostate-cancer-at-high-or-very-high-risk-of-recurrence-receiving-external-beam-radiotherapy-to-the-prostate-who-were-prescribed-adjuvant-hormonal-therapy-gnrh-agonist-or-antagonist" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20170701134201/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://qualitymeasures.ahrq.gov/summaries/summary/49129/prostate-cancer-percentage-of-patients-regardless-of-age-with-a-diagnosis-of-prostate-cancer-at-high-or-very-high-risk-of-recurrence-receiving-external-beam-radiotherapy-to-the-prostate-who-were-prescribed-adjuvant-hormonal-therapy-gnrh-agonist-or-antagonist&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20170701134201/mailto:/?Subject=AHRQ: Prostate cancer: percentage of patients, regardless of age, with a diagnosis of prostate cancer at high or very high risk of recurrence, receiving external beam radiotherapy to the prostate who were prescribed adjuvant hormonal therapy (GnRH agonist or antagonist).&amp;body=https://qualitymeasures.ahrq.gov/summaries/summary/49129/prostate-cancer-percentage-of-patients-regardless-of-age-with-a-diagnosis-of-prostate-cancer-at-high-or-very-high-risk-of-recurrence-receiving-external-beam-radiotherapy-to-the-prostate-who-were-prescribed-adjuvant-hormonal-therapy-gnrh-agonist-or-antagonist" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Quality Measures Clearinghouse (NQMC). Measure summary: Prostate cancer: percentage of patients, regardless of age, with a diagnosis of prostate cancer at high or very high risk of recurrence, receiving external beam radiotherapy to the prostate who were prescribed adjuvant hormonal therapy (GnRH agonist or antagonist). In: National Quality Measures Clearinghouse (NQMC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2014 Nov 01. [cited 2017 Jul 01]. Available: https://www.qualitymeasures.ahrq.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/citedownload/49129?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/citedownload/49129?format=enw">EndNote</a></li>
                            <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/citedownload/49129?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/citedownload/49129?format=txt">Medlars</a></li>
                            <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/citedownload/49129?format=ris">ProCite</a></li>
                            <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/citedownload/49129">RefWorks</a></li>
                            <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/citedownload/49129?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="49129" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="563" class="accordion-title section-563 is-active" role="tab" aria-expanded="true"><a href="#">Measure Domain</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Primary Measure Domain</a></h3>
                    <p>Clinical Quality Measures: Process</p>
                        <h3><a href="#">Secondary Measure Domain</a></h3>
                    <p>Does not apply to this measure</p>

            </div>
                <h2 id="566" class="accordion-title section-566 is-active" role="tab" aria-expanded="true"><a href="#">Brief Abstract</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description</a></h3>
                    <p><div class="content_para"><p>This measure is used to assess the percentage of patients, regardless of age, with a diagnosis of prostate cancer at high or very high risk of recurrence, receiving external beam radiotherapy to the prostate who were prescribed adjuvant hormonal therapy (GnRH [gonadotropin-releasing hormone] agonist or antagonist).</p></div></p>
                        <h3><a href="#">Rationale</a></h3>
                    <p><div class="content_para"><p>If receiving external beam radiotherapy as primary therapy, prostate cancer patients with a high or very high risk of recurrence should also be prescribed hormonal therapy, which has been shown to increase the effectiveness of the radiotherapy and may also prolong survival.*</p>
<p class="Note">*The following clinical recommendation statements are quoted <span style="text-decoration: underline;">verbatim</span> from the referenced clinical guidelines and represent the evidence base for the measure:</p>
<p class="Note">When counseling patients regarding treatment options, physicians should consider the following:</p>
<p class="Note">Based on results of two randomized controlled clinical trials, the use of adjuvant and concurrent hormonal therapy may prolong survival in the patient who has opted for radiotherapy (Thompson et al., 2007).</p>
<p class="Note">High risk patients who are considering specific treatment options should be informed of findings of recent high quality clinical trials, including that for those considering external beam radiotherapy, use of hormonal therapy combined with conventional radiotherapy may prolong survival (Thompson et al., 2007).</p>
<p class="Note">Men with prostate cancer that is clinically localized stage T3a, Gleason score 8 to 10, or prostate-specific antigen (PSA) level greater than 20 ng/mL are categorized by the National Comprehensive Cancer Network (NCCN) guidelines panel as high risk. Patients with multiple adverse factors may be shifted into the very high-risk category. The preferred treatment is external beam radiation therapy (EBRT) in conjunction with 2 to 3 years of androgen deprivation therapy (ADT) (category 1); ADT alone is insufficient. In particular, patients with low-volume, high-grade tumor warrant aggressive local radiation combined with typically 2 or 3 years of ADT. The combination of EBRT and brachytherapy, with or without ADT (typically 2 or 3 years), is another primary treatment option. However, the optimal duration of ADT in this setting remains unclear. (NCCN, 2015). </p>
<p class="Note">Patients at very high risk (locally advanced) are defined by the NCCN guidelines as those with clinical stage T3b to T4, primary Gleason pattern 5, or more than 4 cores with Gleason score 8 to 10. The options for this group include: 1) EBRT and long-term ADT (category 1); 2) EBRT plus brachytherapy with or without long-term ADT; 3) radical prostatectomy plus (Pelvic lymph node dissection [PLND]) in selected patients with no fixation to adjacent organs; or 4) ADT for patients not eligible for definitive therapy. (NCCN, 2015).</p>
<p class="Note"><strong>Note</strong>: All aforementioned NCCN guideline recommendation statements are category 2A unless otherwise specified. </p></div></p>
                        <h3><a href="#">Evidence for Rationale</a></h3>
                    <p><table><tr><td>American Urological Association (AUA), American Medical Association-convened Physician Consortium for Performance Improvement® (PCPI®). Prostate cancer physician performance measurement set. Linthicum (MD): American Urological Association (AUA); 2014 Nov. 19 p. </td></tr></table></p>
                    <p><table><tr><td>National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology: prostate cancer. Version 2. Fort Washington (PA): National Comprehensive Cancer Network (NCCN); 2015. </td></tr></table></p>
                    <p><table><tr><td>Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen CM. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007 Jun;177(6):2106-131. [123 references]</td></tr></table></p>
                        <h3><a href="#">Primary Health Components</a></h3>
                    <p><div class="content_para"><p>Prostate cancer; high risk of recurrence; external beam radiotherapy; adjuvant hormonal therapy; gonadotropin-releasing hormone (GnRH) agonist or antagonist</p></div></p>
                        <h3><a href="#">Denominator Description</a></h3>
                    <p><div class="content_para"><p>All patients, regardless of age, with a diagnosis of prostate cancer at high or very high risk of recurrence receiving external beam radiotherapy to the prostate (see the related "Denominator Inclusions/Exclusions" field)</p></div></p>
                        <h3><a href="#">Numerator Description</a></h3>
                    <p><div class="content_para"><p>Patients who were prescribed adjuvant hormonal therapy (gonadotropin-releasing hormone [GnRH] agonist or antagonist) (see the related "Numerator Inclusions/Exclusions" field)</p></div></p>

            </div>
                <h2 id="573" class="accordion-title section-573 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Measure</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Criterion of Quality for the Measure</a></h3>
                    <p><ul><li>A clinical practice guideline or other peer-reviewed synthesis of the clinical research evidence</li></ul></p>
                        <h3><a href="#">Additional Information Supporting Need for the Measure</a></h3>
                    <p><div class="content_para"><p>Unspecified</p></div></p>
                        <h3><a href="#">Extent of Measure Testing</a></h3>
                    <p><div class="content_para"><p>The American Medical Association (AMA)-convened Physician Consortium for Performance Improvement (PCPI) in collaboration with the American Society of Clinical Oncology (ASCO), American Society for Radiation Oncology (ASTRO) and American Urological Association (AUA) conducted a testing project to ensure that the prostate cancer measures were feasible to implement, valid and reliable. Overall, the measures were found to be valid and reliable.</p>
<p><em>Face Validity Testing</em></p>
<p>Face validity of the measure score was assessed for three of the six prostate cancer measures. The Prostate Cancer Work Group members were asked to empirically assess face validity of the measure. The expert panel consisted of 19 members, whose specialties include urology, methodology, clinical oncology, radiation oncology, pathology, family medicine, and consumer and health plan representatives.</p>
<p>After the measure was fully specified, the work group was asked to rate their agreement with the following statement: "The scores obtained from the measure, as specified, will provide an accurate reflection of quality and can be used to distinguish good and poor quality."</p>
<p><em>Face Validity Testing Results</em></p>
<table border="1" summary="Face Validity Results">
    <thead>
        <tr>
            <th width="25%" class="Center" valign="top" rowspan="2">Measure Number and Title</th>
            <th width="10%" class="Center" valign="top" rowspan="2">N</th>
            <th width="15%" class="Center" valign="top" rowspan="2">Mean Rating</th>
            <th width="25%" class="Center" valign="top" rowspan="2">Percentage in Top Two Categories (4 and 5)</th>
            <th width="25%" class="Center" valign="top" colspan="5">Frequency Distribution of Ratings*</th>
        </tr>
        <tr>
            <th class="Center" valign="top">1</th>
            <th class="Center" valign="top">2</th>
            <th class="Center" valign="top">3</th>
            <th class="Center" valign="top">4</th>
            <th class="Center" valign="top">5</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">#3 Avoidance of Overuse Measure - Bone Scan for Staging Low-Risk Patients</td>
            <td class="Center" valign="top">13</td>
            <td class="Center" valign="top">4.62</td>
            <td class="Center" valign="top">92.31%</td>
            <td class="Center" valign="top">0</td>
            <td class="Center" valign="top">1</td>
            <td class="Center" valign="top">0</td>
            <td class="Center" valign="top">2</td>
            <td class="Center" valign="top">10</td>
        </tr>
        <tr>
            <td valign="top">#5 Adjuvant Hormonal Therapy for High-Risk Patients</td>
            <td class="Center" valign="top">14</td>
            <td class="Center" valign="top">4.57</td>
            <td class="Center" valign="top">92.86%</td>
            <td class="Center" valign="top">0</td>
            <td class="Center" valign="top">0</td>
            <td class="Center" valign="top">1</td>
            <td class="Center" valign="top">4</td>
            <td class="Center" valign="top">9</td>
        </tr>
        <tr>
            <td valign="top">#6 Three-Dimensional Radiotherapy</td>
            <td class="Center" valign="top">14</td>
            <td class="Center" valign="top">3.93</td>
            <td class="Center" valign="top">78.57%</td>
            <td class="Center" valign="top">2</td>
            <td class="Center" valign="top">1</td>
            <td class="Center" valign="top">0</td>
            <td class="Center" valign="top">4</td>
            <td class="Center" valign="top">7</td>
        </tr>
    </tbody>
</table>
<p class="Note">*Scale from 1 to 5, where 1 (Strongly Disagree); 3 (Neither Agree nor Disagree); 5 (Strongly Agree)</p>
<p><em>Reliability Testing</em></p>
<p>Inter-rater reliability testing (i.e., manual review of the patient medical record by two trained clinical abstractors and comparison of their individual findings) was conducted at five practice sites on all six of the prostate cancer measures. These sites represent various types, locations, and sizes. Agreement rates were calculated at the measure level for the denominator, numerator and exceptions categories. Measure agreement was established based on the results of this analysis.</p>
<p><em>Reliability Testing Results</em></p>
<p>The PCPI measure testing project revealed that all six of the measures demonstrated almost perfect agreement in the numerator category.</p></div></p>
                        <h3><a href="#">Evidence for Extent of Measure Testing</a></h3>
                    <p><table><tr><td>American Urological Association (AUA), American Medical Association-convened Physician Consortium for Performance Improvement® (PCPI®). Prostate cancer physician performance measurement set. Linthicum (MD): American Urological Association (AUA); 2014 Nov. 19 p. </td></tr></table></p>

            </div>
                <h2 id="580" class="accordion-title section-580 is-active" role="tab" aria-expanded="true"><a href="#">State of Use of the Measure</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">State of Use</a></h3>
                    <p>Current routine use</p>
                        <h3><a href="#">Current Use</a></h3>
                    <p>Internal quality improvement</p>
                    <p>Pay-for-reporting</p>
                    <p>Professional certification</p>
                    <p>Public reporting</p>

            </div>
                <h2 id="583" class="accordion-title section-583 is-active" role="tab" aria-expanded="true"><a href="#">Application of the Measure in its Current Use</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Measurement Setting</a></h3>
                    <p>Ambulatory/Office-based Care</p>
                    <p>Ambulatory Procedure/Imaging Center</p>
                    <p>Hospital Outpatient</p>
                        <h3><a href="#">Professionals Involved in Delivery of Health Services</a></h3>
                    <p>Physicians</p>
                        <h3><a href="#">Least Aggregated Level of Services Delivery Addressed</a></h3>
                    <p>Individual Clinicians or Public Health Professionals</p>
                        <h3><a href="#">Statement of Acceptable Minimum Sample Size</a></h3>
                    <p>Does not apply to this measure</p>
                        <h3><a href="#">Target Population Age</a></h3>
                    <p><div class="content_para"><p>All ages</p></div></p>
                        <h3><a href="#">Target Population Gender</a></h3>
                    <p>Male (only)</p>

            </div>
                <h2 id="660" class="accordion-title section-660 is-active" role="tab" aria-expanded="true"><a href="#">National Strategy for Quality Improvement in Health Care</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">National Quality Strategy Aim</a></h3>
                    <p>Better Care</p>
                        <h3><a href="#">National Quality Strategy Priority</a></h3>
                    <p>Prevention and Treatment of Leading Causes of Mortality</p>

            </div>
                <h2 id="590" class="accordion-title section-590 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Health Care Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Getting Better</p>
                    <p>Living with Illness</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>

            </div>
                <h2 id="593" class="accordion-title section-593 is-active" role="tab" aria-expanded="true"><a href="#">Data Collection for the Measure</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Case Finding Period</a></h3>
                    <p><div class="content_para"><p>Unspecified</p></div></p>
                        <h3><a href="#">Denominator Sampling Frame</a></h3>
                    <p>Patients associated with provider</p>
                        <h3><a href="#">Denominator (Index) Event or Characteristic</a></h3>
                    <p>Clinical Condition</p>
                    <p>Patient/Individual (Consumer) Characteristic</p>
                    <p>Therapeutic Intervention</p>
                        <h3><a href="#">Denominator Time Window</a></h3>
                    <p>Does not apply to this measure</p>
                        <h3><a href="#">Denominator Inclusions/Exclusions</a></h3>
                    <p><div class="content_para"><p><strong>Inclusions</strong><br/>
All patients, regardless of age, with a diagnosis of prostate cancer at high or very high risk* of recurrence receiving external beam radiotherapy to the prostate</p>
<p class="Note"><strong>Note</strong>: </p>
<ul class="Note" style="list-style-type: disc;">
    <li>Only male patients with prostate cancer with high or very high risk of recurrence will be counted in the performance denominator of this measure. </li>
    <li>Refer to the original measure documentation for administrative codes. </li>
</ul>
<p class="Note">*<strong>Risk Strata</strong>:</p>
<ul class="Note" style="list-style-type: disc;">
    <li><em>Very Low Risk</em>: Prostate-specific antigen (PSA) less than 10 ng/mL; AND Gleason score 6 or less; AND clinical stage T1c; AND presence of disease in fewer than 3 biopsy cores; AND less than or equal to 50% prostate cancer involvement in any core; AND PSA density less than or equal to 0.15 ng/mL/cm&sup3;. </li>
    <li><em>Low Risk</em>: PSA less than 10 ng/mL; AND Gleason score 6 or less; AND clinical stage T1 to T2a. </li>
    <li><em>Intermediate Risk</em>: PSA 10 to 20 ng/mL; OR Gleason score 7; OR clinical stage T2b to T2c. </li>
    <li><em>High Risk</em>: PSA greater than 20 ng/mL; OR Gleason score 8 to 10; OR clinically localized stage T3a. Note: Patients with multiple adverse factors may be shifted into the very high risk category. </li>
    <li><em>Very High Risk</em>: Clinical stage T3b to T4; OR primary Gleason pattern 5; OR more than 4 cores with Gleason score 8 to 10. </li>
</ul>
<p><strong>Exclusions</strong><br/>
Unspecified</p>
<p><strong>Exceptions</strong></p>
<ul style="list-style-type: disc;">
    <li>Documentation of medical reason(s) for not prescribing/administering adjuvant hormonal therapy (e.g., salvage therapy) </li>
    <li>Documentation of patient reason(s) for not prescribing/administering adjuvant hormonal therapy </li>
</ul></div></p>
                        <h3><a href="#">Exclusions/Exceptions</a></h3>
                    <p>Medical factors addressed</p>
                    <p>Patient factors addressed</p>
                        <h3><a href="#">Numerator Inclusions/Exclusions</a></h3>
                    <p><div class="content_para"><p><strong>Inclusions</strong><br/>
Patients who were prescribed* adjuvant hormonal therapy (gonadotropin-releasing hormone [GnRH] agonist or antagonist)</p>
<p class="Note"><strong>Note</strong>: Refer to the original measure documentation for administrative codes.</p>
<p class="Note">*<em>Prescribed</em>: Includes patients who are currently receiving medication(s) that follow the treatment plan recommended at an encounter during the reporting period, even if the prescription for that medication was ordered prior to the encounter.</p>
<p><strong>Exclusions</strong><br/>
Unspecified</p></div></p>
                        <h3><a href="#">Numerator Search Strategy</a></h3>
                    <p>Fixed time period or point in time</p>
                        <h3><a href="#">Data Source</a></h3>
                    <p>Administrative clinical data</p>
                    <p>Electronic health/medical record</p>
                    <p>Paper medical record</p>
                    <p>Registry data</p>
                        <h3><a href="#">Type of Health State</a></h3>
                    <p>Does not apply to this measure</p>
                        <h3><a href="#">Instruments Used and/or Associated with the Measure</a></h3>
                    <p><div class="content_para"><p>Unspecified</p></div></p>

            </div>
                <h2 id="605" class="accordion-title section-605 is-active" role="tab" aria-expanded="true"><a href="#">Computation of the Measure</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Measure Specifies Disaggregation</a></h3>
                    <p>Does not apply to this measure</p>
                        <h3><a href="#">Scoring</a></h3>
                    <p>Rate/Proportion</p>
                        <h3><a href="#">Interpretation of Score</a></h3>
                    <p>Desired value is a higher score</p>
                        <h3><a href="#">Allowance for Patient or Population Factors</a></h3>
                    <p>Unspecified</p>
                        <h3><a href="#">Standard of Comparison</a></h3>
                    <p>Internal time comparison</p>

            </div>
                <h2 id="615" class="accordion-title section-615 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Original Title</a></h3>
                    <p><div class="content_para"><p>Measure #5: adjuvant hormonal therapy for high risk prostate cancer patients.</p></div></p>
                        <h3><a href="#">Measure Collection Name</a></h3>
                    <p>Prostate Cancer Physician Performance Measurement Set</p>
                        <h3><a href="#">Submitter</a></h3>
                    <p>American Urological Association - Medical Specialty Society</p>
                        <h3><a href="#">Developer</a></h3>
                    <p>American Urological Association - Medical Specialty Society</p>
                    <p>Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration</p>
                        <h3><a href="#">Funding Source(s)</a></h3>
                    <p><div class="content_para"><p>Unspecified</p></div></p>
                        <h3><a href="#">Composition of the Group that Developed the Measure</a></h3>
                    <p><div class="content_para"><p><em>Prostate Cancer Work Group</em>: Ian Thompson, MD (<em>Co-Chair</em>, urology); Steven Clauser, PhD (<em>Co-Chair</em>, methodology); Peter Albertsen, MD (urology); Charles Bennett, MD, PhD, MPP (clinical oncology); Michael Cookson, MD (urology); Gregory W. Cotter, MD (radiation oncology); Theodore L. DeWeese, MD (radiation oncology); Mario Gonzalez, MD (pathology); Louis Kavoussi, MD (urology); Eric A. Klein, MD (urology); Colleen Lawton, MD (radiation oncology); W. Robert Lee, MD, MS, Med (radiation oncology); Peter A. S. Johnstone, MD, FACR (radiation oncology); David F. Penson, MD, MPH (urology); Stephen Permut, MD (family medicine); Howard Sandler, MD (radiation oncology); Bill Steirman, MA (consumer representative); John T. Wei, MD (urology); Carol Wilhoit, MD (health plan representative)</p>
<p><em>American Urological Association</em>: Robin Hudson, MPA; Beth Kosiak, PhD</p>
<p><em>American Society for Therapeutic Radiology &amp; Oncology</em>: Emily Wilson; Trisha Crishock, MSW</p>
<p><em>American Medical Association</em>: Karen S. Kmetik, PhD; Mark Antman, DDS, MBA; Kendra Hanley, MS; Diedra Gray, MPH; Kimberly Smuk, RHIA</p>
<p><em>Facilitators</em>: Timothy F. Kresowik, MD; Rebecca A. Kresowik</p>
<p><em>National Committee for Quality Assurance</em>: Phil Renner, MBA</p>
<p><em>Joint Commission on Accreditation of Healthcare Organizations</em>: Lisa Buczkowski, RN, MS; Elvira Ryan, RN</p></div></p>
                        <h3><a href="#">Financial Disclosures/Other Potential Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>Conflicts, if any, are disclosed in accordance with the Physician Consortium for Performance Improvement&reg; conflict of interest policy.</p></div></p>
                        <h3><a href="#">Endorser</a></h3>
                    <p>National Quality Forum</p>
                        <h3><a href="#">NQF Number</a></h3>
                    <p>0390</p>
                        <h3><a href="#">Date of Endorsement</a></h3>
                    <p><div class="content_para"><p>2014 Oct 1</p></div></p>
                        <h3><a href="#">Measure Initiative(s)</a></h3>
                    <p>Physician Quality Reporting System</p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>This measure was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date of Most Current Version in NQMC</a></h3>
                    <p>2014 Nov</p>
                        <h3><a href="#">Measure Maintenance</a></h3>
                    <p><div class="content_para"><p>This measure will be up for maintenance through the National Quality Forum (NQF) in late 2015 or early 2016.</p></div></p>
                        <h3><a href="#">Date of Next Anticipated Revision</a></h3>
                    <p><div class="content_para"><p>Later 2015/early 2016</p></div></p>
                        <h3><a href="#">Measure Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the measure.</p>
<p>This measure updates a previous version: American Urological Association, American Medical Association (AMA)-convened Physician Consortium for Performance Improvement&reg;. Prostate cancer physician performance measurement set. Chicago (IL): American Medical Association (AMA); 2012 Sep. 28 p. </p>
<p>The measure developer reaffirmed the currency of this measure in February 2017. </p></div></p>
                        <h3><a href="#">Source(s)</a></h3>
                    <p><table><tr><td>American Urological Association (AUA), American Medical Association-convened Physician Consortium for Performance Improvement® (PCPI®). Prostate cancer physician performance measurement set. Linthicum (MD): American Urological Association (AUA); 2014 Nov. 19 p. </td></tr></table></p>
                        <h3><a href="#">Measure Availability</a></h3>
                    <p><div class="content_para"><p>Source not available electronically.</p>
<p>For more information, contact the American Urological Association (AUA) at 1000 Corporate Boulevard, Linthicum, MD 21090; Phone: 410-689-3700; Fax: 410-689-3800; Web site: <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/Home/Disclaimer?id=49129&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.auanet.org%2f" title="American Urological Association (AUA) Web site">www.auanet.org</a>&nbsp;<img alt="External Web Site Policy" src="/web/20170701134201im_/https://qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">NQMC Status</a></h3>
                    <p><div class="content_para"><p>This NQMC summary was completed by ECRI Institute on November 3, 2008. The information was verified by the measure developer on December 4, 2008. </p>
<p>This NQMC summary was edited by ECRI Institute on September 28, 2009. </p>
<p>This NQMC summary was retrofitted into the new template on June 9, 2011. </p>
<p>This NQMC summary was edited again by ECRI Institute on April 27, 2012. </p>
<p>This NQMC summary was updated by ECRI Institute on December 5, 2013. The information was not verified by the measure developer.</p>
<p>Stewardship for this measure was transferred from the PCPI to the AUA. AUA informed NQMC that this measure was updated. This NQMC summary was updated by ECRI Institute on May 28, 2015. The information was verified by the measure developer on June 19, 2015.</p>
<p>The information was reaffirmed by the measure developer on February 7, 2017. </p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>This NQMC summary is based on the original measure, which is subject to the measure developer's copyright restrictions.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NQMC Disclaimer</a></h3>
                    <p><p>The National Quality Measures Clearinghouse™ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.</p> 
<p>All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.</p> 
<p>Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the <a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/help-and-about/summaries/inclusion-criteria">NQMC Inclusion Criteria</a>.</p> 
<p>NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding measure content are directed to contact the measure developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->



		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NQMC Measure Summaries</h3>
            <ul>
                <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/help-and-about/summaries/varieties-of-measures-in-nqmc" class="internal-link">Varieties of Measures</a></li>
                <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/help-and-about/quality-measure-tutorials/uses-of-quality-measures" class="internal-link">Uses of Measures</a></li>
                <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/help-and-about/quality-measure-tutorials/selecting-quality-measures" class="internal-link">Selecting Measures</a></li>
            </ul>
            <p><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/help-and-about/summaries/faq" class="help-button">Measure Summary FAQ</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->
        <div class="hhs-block">
            <h3 class="hhs-header">Related HHS Measure</h3>
            <p>From the HHS Measure Inventory</p>
                <p><a target="_blank" class="external-link" href="/web/20170701134201/https://qualitymeasures.ahrq.gov/hhs/content.aspx?id=3822">Prostate Cancer: Adjuvant Hormonal Therapy for High Risk Prostate Cancer Patients: Percentage of patients, regardless of age, with a diagnosis of prostate cancer at high or very high risk of recurrence receiving external beam radiotherapy to the prostate who were prescribed adjuvant hormonal therapy (GnRH [gonadotropin-releasing hormone] agonist or antagonist)</a></p>   
        </div>
        <!-- /.HSS Block -->    

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NQMC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/rssFiles/nqmc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon measure news-list-category-label">Measure Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NQMC:011278</li>
            <li>Dec 2013</li>
        </ul>
       
            <p><a class="" target="" href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/summary/51001/cancer-patient-experience-percentage-of-patients-who-reported-whether-they-have-been-enabled-by-healthcare-professionals-to-share-decisions-about-their-care-and-treatment-on-the-cancer-quality-performance-indicator-qpi-shared-decision-making-measurement-tool">Cancer patient experience: percentage of patients who reported whether they have been enabled by healthcare professionals to share decisions about their care and treatment on the Cancer Quality Performance Indicator (QPI) Shared Decision Making Measurement Tool.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NQMC:011277</li>
            <li>Dec 2013</li>
        </ul>
       
            <p><a class="" target="" href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/summary/51000/cancer-patient-experience-percentage-of-patients-who-reported-whether-they-experienced-excellent-information-provision-from-healthcare-professionals-throughout-their-cancer-care-on-the-cancer-quality-performance-indicator-qpi-information-measurement-tool">Cancer patient experience: percentage of patients who reported whether they experienced excellent information provision from healthcare professionals throughout their cancer care on the Cancer Quality Performance Indicator (QPI) Information Measurement Tool.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NQMC:011276</li>
            <li>Dec 2013</li>
        </ul>
       
            <p><a class="" target="" href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/summary/50999/cancer-patient-experience-percentage-of-patients-who-reported-whether-they-experienced-excellent-communication-from-healthcare-professionals-throughout-their-cancer-care-on-the-cancer-quality-performance-indicator-qpi-communication-measurement-tool">Cancer patient experience: percentage of patients who reported whether they experienced excellent communication from healthcare professionals throughout their cancer care on the Cancer Quality Performance Indicator (QPI) Communication Measurement Tool.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NQMC:011181</li>
            <li>Aug 2016</li>
        </ul>
       
            <p><a class="" target="" href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/summary/50895/cervical-cancer-proportion-of-patients-with-cervical-cancer-undergoing-radical-radiotherapy-who-receive-concurrent-chemotherapy">Cervical cancer: proportion of patients with cervical cancer undergoing radical radiotherapy who receive concurrent chemotherapy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NQMC:011180</li>
            <li>Aug 2016</li>
        </ul>
       
            <p><a class="" target="" href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/summary/50894/cervical-cancer-proportion-of-patients-with-cervical-cancer-undergoing-radical-radiotherapy-external-beam-or-brachytherapy-whose-overall-treatment-time-from-start-to-the-end-of-treatment-is-not-more-than-56-days">Cervical cancer: proportion of patients with cervical cancer undergoing radical radiotherapy (external beam or brachytherapy) whose overall treatment time, from start to the end of treatment, is not more than 56 days.</a></p>
    </div>

    <a class="block-link" href="/web/20170701134201/https://qualitymeasures.ahrq.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/disclaimer?id=49129&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20170701134201im_/https://qualitymeasures.ahrq.gov/UI/images/logo_NQMC_footer.svg">
					  	<img src="/web/20170701134201im_/https://qualitymeasures.ahrq.gov/UI/images/logo_NQMC_footer.png" alt="NQMC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/">Home</a></li>
		                <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/browse/organization" class="parent-link">Measure Summaries</a></li>
						<li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/summaries/submit">Submit Measures</a></li>
						<li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/rss">RSS</a></li>
					    <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/browse/related">Related NGC Guidelines</a></li>
                        <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20170701134201/https://qualitymeasures.ahrq.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
					<li><!-- NGC footer link -->
						<a href="https://web.archive.org/web/20170701134201/https://www.guideline.gov/" target="_blank" class="partner-button ngc">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20170701134201im_/https://qualitymeasures.ahrq.gov/UI/images/logo_footerlink_ngc.svg">
									<img src="/web/20170701134201im_/https://qualitymeasures.ahrq.gov/UI/images/logo_footerlink_ngc.png" alt="National Guidelines Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/NGC footer link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20170701134201/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20170701134201im_/https://qualitymeasures.ahrq.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20170701134201im_/https://qualitymeasures.ahrq.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20170701134201/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20170701134201/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20170701134201js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20170701134201js_/https://qualitymeasures.ahrq.gov/cassette.axd/script/21385f83c5bf538e76ab38fa354f052b707282c0/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 13:42:01 Jul 01, 2017 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 18:19:22 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 93.637 (3)
  esindex: 0.008
  captures_list: 111.603
  CDXLines.iter: 14.235 (3)
  PetaboxLoader3.datanode: 94.459 (4)
  exclusion.robots: 0.2
  exclusion.robots.policy: 0.171
  RedisCDXSource: 0.585
  PetaboxLoader3.resolve: 446.355
  load_resource: 511.114
-->